GE Healthcare acquires Puridify


Chalfont St Giles, UK – 28 November 2017 – GE Healthcare has completed the acquisition of Puridify, a bioprocessing SME that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing, promising faster mass transfer, scalability and ease of use.

Read more…